Regulatory Open Forum

 View Only
  • 1.  14971, updates to Risk Mgt

    Posted 06-Feb-2016 07:19
    Edited by Thomas Faris 07-Feb-2016 16:00


  • 2.  RE: 14971, updates to Risk Mgt

    Posted 06-Feb-2016 09:25

    There are some clarifications in order.

    ISO 14971:2007 has not been updated. The international version remains at the 2007 revision and is among the recognized standards in both the US and Canada. What has changed is EN ISO 14971:2012 which seeks to address discrepancies between the international standard and the EU product directives related to medical devices.

    In terms of ALARP, the content deviation refers to As Far As Possible, which is usually stated as AFAP. It concludes, “Accordingly, manufacturers and Notified Bodies may not apply the ALARP concept with regard to economic considerations.” ALARP is a risk reduction methodology (not the name of a risk region) composed of technical means and economic means. The content deviation eliminates economic means (making the device an unsound economic proposition) from the tool box. It does not change to acceptability criteria or the need to reduce a risk to an acceptable level.

    You say, “user labeling is to provide no primary risk mitigating value”. First, the correct term is risk reduction, not mitigation. The standard doesn’t use the word mitigation, since it has a different meaning.

    The content deviation is about residual risk, not using information for safety as a risk reduction measure. In fact, for the MDD, there is a content deviation that requires information for safety as a risk reduction measure. This is described as the cumulative approach to the application of risk reduction options. The content deviation in question, for the MDD, is about a requirement to inform users about the residual risks, and concludes that manufacturers cannot use this information, i.e., the residual risk information, to reduce risk. The misunderstanding often arises from failure to distinguish between information for safety and disclosing residual risk. See Annex J of the standard for a discussion of the differences.

    ------------------------------
    Dan O'Leary
    Swanzey NH
    United States



  • 3.  RE: 14971, updates to Risk Mgt

    Posted 07-Feb-2016 23:09

    There are some future issues to pay attention to related to this discussion. First of all, the Medical Device Directives will be replaced by new EU Regulations, which will shortly be released.  Second, ISO 13485:2003 and EN ISO 13485:2012 are being replaced by new versions, ISO 13485:2016 and EN ISO 13485:2016.  While all f these have transition periods associated with implementation, as wise company would include these new requirements in their plans for the future.  It is expected that the ISO document and EN ISO will have three year transitions, but there is an asterisk.  It is possible that new certificates for the standards, may not be issued after two years.

    The new ISO 13485 and EN ISO 13485 does contain over 47 references to the term "risk" in the complete document, including requirements and annexes.  This is far more than in the previous revision, which did not break the single digits.  So you will see an expanded emphasis on risk in upcoming audits for certifications to the standards.  

    As for ISO 14971, the technical committee will meet this summer to determine possible revision activity.  As always, revisions take considerable time, and a new release will not be forthcoming any time soon.  In fact, it is possible no decision could be made for some time.  Companies, however, should include ISO TR 24971 information in any updates to their risk management system.  This often overlooked document contains extremely valuable information, such as how to use product and process safety standards as part of the risk management process.

    ------------------------------
    Edwin Bills RAC, MA
    Principal Consultant
    ELB Consulting
    Overland Park KS
    United States



  • 4.  RE: 14971, updates to Risk Mgt

    Posted 08-Feb-2016 10:41
    Thom,

    You seem to have nicely intertwined practical perspectives between regulatory requirements and personal injury issues.  

    "Our user guides may convey the need to for users to comply with certain best practices or professional industry standards of care. Also, even a blind man can see that user warnings in our labeling are required to adequately reduce risk in certain cases."

    As for regulatory requirements, per MDD as an example, it uses the language "as far as possible" (AFAP).  Conceptually, it may refer to "as low as possible." 

    I consider "how far" is far enough is a question of law and fact. 

    Anyhow, the (EN) ISO 14971 (2012) ("standard") uses the language "ALARP."  Professionals never mention about one thing, but what it is critical to consider is MP3, which is my own coined term (aka, "3MPs").  I go with MP3 to memorize it easy.  All interested parties should figure out what I am referring to by reading the intro and scope of the ISO 14971. 

    You use the terms "warnings" in connection with "to adequately reduce risk..."   Such language clearly manifests not meeting MDD requirements when you claim your compliance to the EN ISO 14971:2012. 

    To better meet the standard, if applicable, your risk management documentation should be revised to accurately reflect your compliance to the MDD ERs.  

    If you are potentially envisioning personal injury prevention practices (potential personal injury litigation), it becomes critical to doubly ensure that potential issues (e.g., design/manufacturing defects, failure to warn, failure to adequately warn, reasonableness, professional standard of care) should be addressed or reflected in your user guides/documentation.

    Thank you.  

    s/ David
    ______________________________________________
    Dr. David Lim, Ph.D., RAC, ASQ-CQA 
    Phone (Toll-Free): 1-(800) 321-8567



    "Knowledge is power only when it is practiced and put into action." - Regulatory Doctor

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.